Detailansicht

Wissensnetz

Person

Jörg Haupenthal (1979-)

Immunbiologe

Name	Jörg Haupenthal
Zeit	1979- (Lebensdaten)
Ort	Lebach/Saar (Geburtsort) Deutschland
Beruf	Immunbiologe (charakteristischer Beruf)
Beziehung	Genetik (Studienfach)
Weitere Angaben	Diss. Naturwissenschaften, Universität Saarbrücken, Fakultät 2 - Medizin
Datensatztyp	Person
GND-Nummer	132088029
Datensatz-ID	132088029
Beteiligt an alle anzeigen Clean Synthetic Strategies to Biologically Active Molecules from Lignin : A Green Path to Drug Discovery Spray drying of a zinc complexing agent for inhalation therapy of pulmonary fibrosis Spray drying of a zinc complexing agent for inhalation therapy of pulmonary fibrosis Clean Synthetic Strategies to Biologically Active Molecules from Lignin: A Green Path to Drug Discovery Clean Synthetic Strategies to Biologically Active Molecules from Lignin: A Green Path to Drug Discovery Exploring the Translational Gap of a Novel Class of Escherichia coli IspE Inhibitors Exploring the translational gap of a novel class of escherichia coli IspE inhibitors Exploring the Translational Gap of a Novel Class of Escherichia coli IspE Inhibitors Inhibition of Collagenase Q1 of Bacillus cereus as a Novel Antivirulence Strategy for the Treatment of Skin‐Wound Infections An Efficient Way to Screen Inhibitors of Energy-Coupling Factor (ECF) Transporters in a Bacterial Uptake Assay Discovery of novel drug-like antitubercular hits targeting the MEP pathway enzyme DXPS by strategic application of ligand-based virtual screening Inhibition of Collagenase Q1 of Bacillus cereus as a Novel Antivirulence Strategy for the Treatment of Skin-Wound Infections Bacteriomimetic Liposomes Improve Antibiotic Activity of a Novel Energy-Coupling Factor Transporter Inhibitor Bacteriomimetic Liposomes Improve Antibiotic Activity of a Novel Energy-Coupling Factor Transporter Inhibitor Hit-optimization using target-directed dynamic combinatorial chemistry : development of inhibitors of the anti-infective target 1-deoxy-d-xylulose-5-phosphate synthase N-Aryl mercaptoacetamides as potential multi-target inhibitors of metallo-β-lactamases (MBLs) and the virulence factor LasB from Pseudomonas aeruginosa Phosphonate as a Stable Zinc-Binding Group for "Pathoblocker" Inhibitors of Clostridial Collagenase H (ColH) Substrate-Inspired Fragment Merging and Growing Affords Efficacious LasB Inhibitors Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach Reduced efficacy of the plk1 inhibitor bi 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma Therapie des hepatozellulären Karzinoms durch RNAi-vermittelte Suppression der Plk1-Expression Und Gott sah, dass es gut war : der moderne Atheismus: Erleuchtung oder Irrweg?

Hinweis

Die Betaversion beinhaltet noch nicht alle Funktionen und Informationen des Katalogs des DNB-Portals. Falls Sie Informationen vermissen oder ein Medium bestellen wollen, besuchen Sie bitte die entsprechende Seite im Katalog des DNB-Portals über folgenden Link:

Katalog der Deutschen Nationalbibliothek

Clean Synthetic Strategies to Biologically Active Molecules from Lignin : A Green Path to Drug Discovery

Spray drying of a zinc complexing agent for inhalation therapy of pulmonary fibrosis

Spray drying of a zinc complexing agent for inhalation therapy of pulmonary fibrosis

Clean Synthetic Strategies to Biologically Active Molecules from Lignin: A Green Path to Drug Discovery **

Clean Synthetic Strategies to Biologically Active Molecules from Lignin: A Green Path to Drug Discovery **

Exploring the Translational Gap of a Novel Class of Escherichia coli IspE Inhibitors

Exploring the translational gap of a novel class of escherichia coli IspE inhibitors

Exploring the Translational Gap of a Novel Class of Escherichia coli IspE Inhibitors

Inhibition of Collagenase Q1 of Bacillus cereus as a Novel Antivirulence Strategy for the Treatment of Skin‐Wound Infections

An Efficient Way to Screen Inhibitors of Energy-Coupling Factor (ECF) Transporters in a Bacterial Uptake Assay

Discovery of novel drug-like antitubercular hits targeting the MEP pathway enzyme DXPS by strategic application of ligand-based virtual screening

Inhibition of Collagenase Q1 of Bacillus cereus as a Novel Antivirulence Strategy for the Treatment of Skin-Wound Infections

Bacteriomimetic Liposomes Improve Antibiotic Activity of a Novel Energy-Coupling Factor Transporter Inhibitor

Bacteriomimetic Liposomes Improve Antibiotic Activity of a Novel Energy-Coupling Factor Transporter Inhibitor

Hit-optimization using target-directed dynamic combinatorial chemistry : development of inhibitors of the anti-infective target 1-deoxy-d-xylulose-5-phosphate synthase

N-Aryl mercaptoacetamides as potential multi-target inhibitors of metallo-β-lactamases (MBLs) and the virulence factor LasB from Pseudomonas aeruginosa

Phosphonate as a Stable Zinc-Binding Group for "Pathoblocker" Inhibitors of Clostridial Collagenase H (ColH)

Substrate-Inspired Fragment Merging and Growing Affords Efficacious LasB Inhibitors

Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach

Rapid Discovery of Aspartyl Protease Inhibitors Using an Anchoring Approach

Reduced efficacy of the plk1 inhibitor bi 2536 on the progression of hepatocellular carcinoma due to low intratumoral drug levels

Serum microRNA-21 as marker for necroinflammation in hepatitis C patients with and without hepatocellular carcinoma

Therapie des hepatozellulären Karzinoms durch RNAi-vermittelte Suppression der Plk1-Expression

Und Gott sah, dass es gut war : der moderne Atheismus: Erleuchtung oder Irrweg?